Colon cancer phenotype

Aliases

cancer of the colon

Related entities (3)

Mentioned in (74)

Papers in which this entity is mentioned.

• Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
• Rapid brain tumor classification from sparse epigenomic data. (2025)
• Functional analysis of cancer-associated germline risk variants. (2025)
• ENPP1 Immunobiology as a Therapeutic Target. (2023)
• Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients (2023)
• GCparagon: evaluating and correcting GC biases in cell-free DNA at the fragment level. (2023)
• Towards understandings of serine/arginine-rich splicing factors. (2023)
• RNA splicing dysregulation and the hallmarks of cancer. (2023)
• Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking. (2022)
• Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. (2022)
• Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. (2021)
• Alternative splicing: Human disease and quantitative analysis from high-throughput sequencing. (2021)
• Detection and characterization of lung cancer using cell-free DNA fragmentomes. (2021)
• Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases. (2021)
• Macrophage Polarization States in the Tumor Microenvironment. (2021)
• Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. (2020)
• Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. (2020)
• Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
• Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks. (2020)
• Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers. (2020)
• Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. (2020)
• Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project. (2020)
• Alcohol Use in Pregnancy. (2019)
• Fast and robust deconvolution of tumor infiltrating lymphocyte from expression profiles using least trimmed squares. (2019)
• RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues. (2019)
• Quantification of subclonal selection in cancer from bulk sequencing data. (2018)
• Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (2018)
• Tumor fraction in cell-free DNA as a biomarker in prostate cancer. (2018)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes (2018)
• Patterns and mechanisms of structural variations in human cancer. (2018)
• Thymic involution and rising disease incidence with age. (2018)
• OncoKB: A Precision Oncology Knowledge Base. (2017)
• Universal Patterns of Selection in Cancer and Somatic Tissues. (2017)
• Patient-derived xenografts undergo mouse-specific tumor evolution. (2017)
• Comprehensive Analysis of Hypermutation in Human Cancer. (2017)
• Fragment Length of Circulating Tumor DNA. (2016)
• Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers. (2016)
• Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. (2016)
• Development and clinical application of an integrative genomic approach to personalized cancer therapy. (2016)
• ENVE: a novel computational framework characterizes copy-number mutational landscapes in colorectal cancers from African American patients. (2015)
• Design and bioinformatics analysis of genome-wide CLIP experiments. (2015)
• CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma. (2015)
• Robust enumeration of cell subsets from tissue expression profiles. (2015)
• Reconstructing A/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. (2015)
• Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. (2015)
• RADIA: RNA and DNA integrated analysis for somatic mutation detection. (2014)
• PVT1 dependence in cancer with MYC copy-number increase. (2014)
• Inferring tumour purity and stromal and immune cell admixture from expression data. (2013)
• Cancer genome landscapes. (2013)
• Fusion genes and their discovery using high throughput sequencing. (2013)
• Mutational heterogeneity in cancer and the search for new cancer-associated genes. (2013)
• Effects of alcohol on the endocrine system. (2013)
• Charting a dynamic DNA methylation landscape of the human genome. (2013)
• Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells. (2013)
• LIN28B promotes growth and tumorigenesis of the intestinal epithelium via Let-7. (2013)
• Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. (2012)
• High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. (2012)
• Myeloid cells in tumor inflammation. (2012)
• Managing incidental findings and research results in genomic research involving biobanks and archived data sets. (2012)
• Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats. (2012)
• Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus. (2012)
• Alcohol consumption and non-communicable diseases: epidemiology and policy implications. (2011)
• Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. (2011)
• Automated medical image segmentation techniques. (2010)
• Integrative analysis of the melanoma transcriptome. (2010)
• Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. (2010)
• MicroRNAs: master regulators of ethanol abuse and toxicity? (2010)
• Down syndrome--recent progress and future prospects. (2009)
• Circulating microRNAs as stable blood-based markers for cancer detection. (2008)
• 3' end mRNA processing: molecular mechanisms and implications for health and disease. (2008)
• Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. (2008)
• Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. (2006)
• Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway. (2006)
• Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation. (2004)

Merged raw entities (2)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.